ArisGlobal, a provider of solutions to the life science industry, has announced the immediate availability of agEncoder 2.1, its comprehensive coding and dictionary management system.
The new release, certified by the Uppsala Monitoring Center to utilize the full features of WHO DRUG dictionary, offers new capabilities such as multi-lingual MedDRA support (including English, French, German, Italian, Japanese, Spanish, Portuguese, Czech, Hungarian and Dutch). agEncoder also extends support of standardized MedDRA Queries (SMQs) and Custom MedDRA Queries (CMQs) including improved search capabilities and full impact analysis of new MedDRA versions.
Integrated with ArisGlobal’s pharmacovigilance and safety system (ARISg) and the company’s electronic data capture technology (agCapture), agEncoder offers comprehensive dictionary management and centralized coding with integrated workflow to ensure accurate and consistent coding of clinical terms. Further functionality enhancements include improved search capability of the WHO-DD browser (e.g. search for active ingredients, search for preferred terms, generic terms, drug synonyms and umbrella search) and the use of eSignature.
Commented Mathias Poensgen, product manager. “agEncoder 2.1 serves the coding needs of both pharmacovigilance and clinical teams to improve the quality as well as the efficiency of their coding process.”
agEncoder 2.1 will be available to customers as a licensed, on-premise solution or as a hosted solution via agOnDemand™, ArisGlobal's comprehensive Software-as-a-Service (SaaS) delivery platform.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.